Menu
12/05/2005
Ecstasy and anti-depressants could halt cancer growth
Scientists have discovered possible cancer-busting properties in ecstasy and anti-depressant drugs.
Research at the University of Birmingham, backed by the Leukaemia Research Fund, discovered that over half of lymphoma (cancers of white blood cells) samples studied responded in test tubes to the growth-halting properties of psychotropic drugs. These included ecstasy and weight-loss pills, which are amphetamine derivatives and antidepressants such as Prozac.
The scientists say that these findings, published in the FASEB Journal, offer potentially “important leads” to finding possible new cancer treatments.
During the research 17 samples, including cases of acute lymphoblastic leukaemia and multiple myeloma, were treated. The scientists found that when exposed to antidepressants, nine of the 17 samples’ growth rate was slowed down, while eleven of the samples reacted similarly to one or both of the amphetamine derivatives.
Professor John Gordon, from the University of Birmingham’s Medical School, said: “We think that a range of psychotropic agents that are being used, or sometimes abused, for other reasons will now help us in our fight against all different types of cancer.”
Professor Gordon added: “We are excited that drugs like Prozac are effective in killing these types of cancer cells, as these antidepressants are in such wide circulation and have an impressive safety record.”
However, the application of ecstasy is not so straightforward. Co-lead scientist Dr Nick Barnes explained: “We must stress very strongly that we couldn’t use ecstasy itself as a therapeutic compound, as the dose required to treat the tumour would kill the patient. But perhaps by breaking down the actions of this designer drug, we can extract its cancer killing properties from more general toxic effects associated with its use.”
The Leukaemia Research Fund has welcomed the findings. The fund’s scientific director, Dr David Grant, said: “Around 10,000 people are diagnosed with a lymphoma in the UK each year and so the possibility that some of these patients can be treated with antidepressants that have cancer-killing properties is truly remarkable.”
The scientists at the University of Birmingham have been working in this area for five years. This latest study builds on previous findings that discovered that Prozac is effective in killing cells specifically from Burkitt’s lymphoma, a common cause of children’s cancer in Africa.
(KMcA/SP)
Research at the University of Birmingham, backed by the Leukaemia Research Fund, discovered that over half of lymphoma (cancers of white blood cells) samples studied responded in test tubes to the growth-halting properties of psychotropic drugs. These included ecstasy and weight-loss pills, which are amphetamine derivatives and antidepressants such as Prozac.
The scientists say that these findings, published in the FASEB Journal, offer potentially “important leads” to finding possible new cancer treatments.
During the research 17 samples, including cases of acute lymphoblastic leukaemia and multiple myeloma, were treated. The scientists found that when exposed to antidepressants, nine of the 17 samples’ growth rate was slowed down, while eleven of the samples reacted similarly to one or both of the amphetamine derivatives.
Professor John Gordon, from the University of Birmingham’s Medical School, said: “We think that a range of psychotropic agents that are being used, or sometimes abused, for other reasons will now help us in our fight against all different types of cancer.”
Professor Gordon added: “We are excited that drugs like Prozac are effective in killing these types of cancer cells, as these antidepressants are in such wide circulation and have an impressive safety record.”
However, the application of ecstasy is not so straightforward. Co-lead scientist Dr Nick Barnes explained: “We must stress very strongly that we couldn’t use ecstasy itself as a therapeutic compound, as the dose required to treat the tumour would kill the patient. But perhaps by breaking down the actions of this designer drug, we can extract its cancer killing properties from more general toxic effects associated with its use.”
The Leukaemia Research Fund has welcomed the findings. The fund’s scientific director, Dr David Grant, said: “Around 10,000 people are diagnosed with a lymphoma in the UK each year and so the possibility that some of these patients can be treated with antidepressants that have cancer-killing properties is truly remarkable.”
The scientists at the University of Birmingham have been working in this area for five years. This latest study builds on previous findings that discovered that Prozac is effective in killing cells specifically from Burkitt’s lymphoma, a common cause of children’s cancer in Africa.
(KMcA/SP)
Related UK National News Stories
Click here for the latest headlines.
25 March 2014
Cancer Research UK Raises Over £8m In Six Days
Cancer Research UK has raised over £8 million in donations in just six days thanks to the #nomakeupselfie trend. The #nomakeupselfie trend isn't something Cancer Research UK started.
Cancer Research UK Raises Over £8m In Six Days
Cancer Research UK has raised over £8 million in donations in just six days thanks to the #nomakeupselfie trend. The #nomakeupselfie trend isn't something Cancer Research UK started.
16 November 2005
Alcohol contributing to mouth cancer rise, report claims
Alcohol is contributing to a rise in mouth cancer cases in the UK, but few people are aware that it is a risk factor for the disease, a survey has warned. Cancer Research UK said that cases of mouth cancer have risen by a quarter over the past ten years – from 3,411 in 1992 to 4,285 in 2001.
Alcohol contributing to mouth cancer rise, report claims
Alcohol is contributing to a rise in mouth cancer cases in the UK, but few people are aware that it is a risk factor for the disease, a survey has warned. Cancer Research UK said that cases of mouth cancer have risen by a quarter over the past ten years – from 3,411 in 1992 to 4,285 in 2001.
29 October 2003
Saturated fats could 'slightly increase' breast cancer risk
Eating large amounts of saturated fat could "slightly increase" the risk of breast cancer, according to a review published in the British Journal of Cancer.
Saturated fats could 'slightly increase' breast cancer risk
Eating large amounts of saturated fat could "slightly increase" the risk of breast cancer, according to a review published in the British Journal of Cancer.
16 April 2012
Celebs Support Early Detection Drive
Sharon Osbourne and football legends Kenny Dalglish and Sir Alex Ferguson are among the celebrities backing a drive to increase the early detection of cancer.
Celebs Support Early Detection Drive
Sharon Osbourne and football legends Kenny Dalglish and Sir Alex Ferguson are among the celebrities backing a drive to increase the early detection of cancer.
08 August 2011
Cancer Survivors 'Should Exercise', Charity Claims
More than a million cancer survivors could be putting themselves at risk of long-term health problems because they are not physically active enough, a report by Macmillan Cancer Support has claimed. The charity's report, Move More, said that of the two million cancer survivors in the UK, around 1.
Cancer Survivors 'Should Exercise', Charity Claims
More than a million cancer survivors could be putting themselves at risk of long-term health problems because they are not physically active enough, a report by Macmillan Cancer Support has claimed. The charity's report, Move More, said that of the two million cancer survivors in the UK, around 1.
-
Northern Ireland WeatherToday:A showery start with outbreaks most frequent north of Lough Neagh and through the morning, before dwindling during the afternoon as the northwest breezes ease and brighter spells of weak sunshine prosper. Maximum temperature 8 °C.Tonight:A dry night, save for a few light showers around the coasts, with prolonged clear spells and light winds bringing a frosty dawn for many in central and southern parts. Minimum temperature -3 °C.
